Discovery of an Oxybenzylglycine Based Peroxisome Proliferator Activated Receptor α Selective Agonist 2-((3-((2-(4-Chlorophenyl)-5-methyloxazol-4-yl)methoxy)benzyl)(methoxycarbonyl)amino)acetic Acid (BMS-687453)Jun Li, Joseph A. Tino, Lawrence J. Kennedy et al.|Journal of Medicinal Chemistry|2010Cited by 41
Discovery of a Potent Acyclic, Tripeptidic, Acyl Sulfonamide Inhibitor of Hepatitis C Virus NS3 Protease as a Back-up to Asunaprevir with the Potential for Once-Daily DosingLi‐Qiang Sun, William Warner, Anthony J. Cocuzza et al.|Journal of Medicinal Chemistry|2016Cited by 31
Discovery of a Partial Glucokinase Activator Clinical Candidate: Diethyl ((3-(3-((5-(Azetidine-1-carbonyl)pyrazin-2-yl)oxy)-5-isopropoxybenzamido)-1<i>H</i>-pyrazol-1-yl)methyl)phosphonate (BMS-820132)Yan Shi, Qi Wang, Wang Ying et al.|Journal of Medicinal Chemistry|2022Cited by 11
Discovery and Preclinical Evaluation of BMS-711939, an Oxybenzylglycine Based PPARα Selective AgonistYan Shi, Joseph A. Tino, Jun Li et al.|ACS Medicinal Chemistry Letters|2016Cited by 6
CCDC 1491198: Experimental Crystal Structure DeterminationLi‐Qiang Sun, Jialong Zhu, Eric Mull et al.|The Cambridge Structural Database|2016Cited by 0